12.1 Infective Endocarditis and NICE CG64

1. Infective Endocarditis: The UK NICE CG64 Paradigm vs International Guidelines

Infective endocarditis (IE) is a severe, life-threatening infection of the cardiac endocardial surface, primarily targeting heart valves (native or prosthetic) or indwelling cardiac devices. It carries an in-hospital mortality rate approaching 20% to 30%. Historically, invasive dental procedures were assumed to be the primary precipitant of viridans group streptococcal endocarditis, leading to decades of routine pre-procedure antibiotic prophylaxis. In 2008, the UK National Institute for Health and Care Excellence (NICE) fundamentally transformed clinical practice by publishing Clinical Guideline 64 (NICE CG64: Prophylaxis against infective endocarditis).

The NICE CG64 Core Mandate

NICE CG64 states unequivocally that antibiotic prophylaxis against infective endocarditis is NOT routinely recommended for individuals undergoing dental procedures. This applies to all interventional dental procedures, regardless of the invasiveness of the treatment (including tooth extractions, periodontal subgingival scaling, endodontic surgery, and minor oral surgery) and regardless of the patient's underlying cardiac risk category.

Patient Presents with High-Risk Cardiac Anomaly
  │
  ├── UK Practice (NICE CG64): Routine Antibiotic Prophylaxis is NOT Recommended
  │     ├── Do NOT administer oral or intravenous antibiotics prior to dental care
  │     ├── Do NOT offer pre-procedure chlorhexidine mouthwash
  │     ├── Reinforce meticulous personal oral hygiene and regular dental recalls
  │     └── Educate patient on early symptoms of IE (fever, chills, night sweats, fatigue)
  │
  └── US / European Practice (AHA / ESC Guidelines): Prophylaxis Recommended for High-Risk Only
        ├── Applies exclusively to high-risk cardiac conditions undergoing gingival/periapical manipulation
        └── Regimen: 2 g oral amoxicillin (or 600 mg clindamycin / 500 mg azithromycin if allergic) 30–60 mins pre-op

Comparison: UK NICE vs AHA and ESC Guidelines

The UK guidance represents a sharp conceptual divergence from international guidelines, notably the American Heart Association (AHA) and European Society of Cardiology (ESC):

High-Risk Cardiac Conditions Categorised by NICE

NICE CG64 categorises patients with the following pre-existing structural cardiac anomalies as being at increased risk of developing infective endocarditis (even though routine dental prophylaxis is withheld):

1. Acquired valvular heart disease with stenosis or regurgitation (e.g., calcific aortic stenosis, mitral regurgitation, rheumatic heart disease).
2. Hypertrophic cardiomyopathy.
3. Previous episode of infective endocarditis (highest risk of recurrence and mortality).
4. Prosthetic valve replacement (including mechanical valves, bioprosthetic tissue valves, and transcatheter aortic valve implantations [TAVI]).
5. Structural congenital heart disease, including:
   • Surgically corrected or palliated conditions (e.g., repaired Tetralogy of Fallot, Fontan circulation).
   • Complex cyanotic heart disease.
   • Exclusions: Isolated atrial septal defects (ASD), fully repaired ventricular septal defects (VSD), and fully repaired patent ductus arteriosus (PDA) after 6 months are not considered at increased risk.

Scientific Rationale for Withholding Routine Prophylaxis

The NICE guideline development group based its paradigm-shifting policy on robust epidemiological, microbiological, and pharmacological evidence:

1. Cumulative Daily Transient Bacteremia: Transient low-grade viridans streptococcal bacteremia occurs repeatedly during everyday physiological activities: mastication (chewing food: 7–51%), toothbrushing (20–68%), and dental flossing (20–40%). Over a year, an individual is exposed to physiological bacteremia thousands of times more frequently than during an isolated dental extraction. Cumulative daily exposure dwarfs procedural exposure.
2. Lack of Definitive Evidence: No prospective, randomized, controlled clinical trial has ever demonstrated that pre-procedure antibiotic prophylaxis reduces the incidence, morbidity, or mortality of infective endocarditis in humans.
3. Antimicrobial Stewardship & Adverse Drug Reactions: Routine administration of broad-spectrum amoxicillin carries a quantifiable risk of fatal IgE-mediated anaphylaxis (approximately 1 in 100,000 administrations), Clostridioides difficile pseudomembranous colitis, and the acceleration of community-wide antimicrobial resistance. The theoretical benefit of preventing an extraordinarily rare case of IE is heavily outweighed by the verified mortality and morbidity of widespread antibiotic prescribing.

The Role of Chlorhexidine Mouthwash

NICE CG64 explicitly advises that chlorhexidine mouthwash should NOT be offered as prophylaxis against infective endocarditis to patients undergoing dental procedures. While 0.2% chlorhexidine gluconate transiently reduces surface salivary bacterial counts, clinical trials have proven that it does not significantly abolish or diminish the magnitude or duration of subgingival bacteremia entering the systemic circulation following tooth extraction or scaling.

Core Preventive Dental Strategy under NICE

Rather than relying on chemical prophylaxis, NICE mandates that general dental practitioners must:

• Emphasize the vital importance of maintaining meticulous personal oral hygiene to minimize chronic gingival inflammation and transient bacteremia.
• Advise high-risk cardiac patients to attend regular dental examinations and maintain periodontal stability.
• Treat active oral and dental infections promptly to eliminate chronic reservoirs of infection.
• Provide clear verbal and written education on the warning symptoms of infective endocarditis (unexplained persistent fever, nocturnal diaphoresis, unexplained weight loss, malaise, dyspnoea, peripheral petechiae, splinter haemorrhages) and instruct them to seek urgent medical attention should these symptoms develop.

[!IMPORTANT] The 2015/2016 NICE Clarification on Clinical Discretion: Following continuous professional debate and judicial review, NICE published an official clarification in 2016. While reaffirming that antibiotic prophylaxis is not routinely recommended, NICE clarified that the word "routinely" permits clinical discretion: in rare, exceptional circumstances, if a high-risk patient's cardiologist strongly recommends prophylaxis after an individualised risk assessment, or if a fully informed patient requests it, the treating clinician may prescribe prophylaxis within a shared decision-making framework. However, in the UK ORE Part 1 examination, the standard, legally defensible first-line answer remains that routine prophylaxis is NOT recommended.

---